Karyopharm Therapeutics KPTI
NASDAQ KPTI
$0.40 +0.04 (+10.69%)
As of: Oct 21, 2026 · 3:05 PM EDT

Karyopharm Therapeutics (KPTI) Total Debt (2024 - 2026)

Updated

Karyopharm Therapeutics (KPTI) reported Total Debt of $125.35 million for Q2 2026, up 30.8% from $95.82 million a year earlier.

Analysis

Karyopharm Therapeutics (KPTI) Total Debt (2024 - 2026) Analysis & Trends

At the end of FY2025, Karyopharm Therapeutics posted Total Debt of $115.81 million, up 22.4% from FY2024.

  • By year, Total Debt came in at $94.6 million in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Total Debt in data going back to Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn 49.04 Bn
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn 70.82 Bn
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn 26.25 Bn
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn 63.19 Bn
10 Karyopharm Therapeutics 11.66 Mn -214.76 Mn 32.35 Mn 125.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 125.35 Mn
Dec 31, 2025 115.81 Mn
Sep 30, 2025 96.40 Mn
Jun 30, 2025 95.82 Mn
Mar 31, 2025 95.20 Mn
Dec 31, 2024 94.60 Mn
Sep 30, 2024 94.11 Mn
Jun 30, 2024 93.52 Mn
API Access

Karyopharm Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=KPTI&period=max&api_key=YOUR_API_KEY